Comments
Loading...
CERo Therapeutics Hldgs (NASDAQ:CERO) Stock, Earnings Estimates, EPS, And Revenue
CERo Therapeutics Hldgs reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 14
EPS
$-0.150
Quarterly Revenue
$0K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of CERo Therapeutics Hldgs using advanced sorting and filters.
Data brought to you by Benzinga APIs
CERo Therapeutics Hldgs (CERO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
CERo Therapeutics Hldgs (CERO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is CERo Therapeutics Hldgs (NASDAQ:CERO) reporting earnings?
CERo Therapeutics Hldgs (CERO) is scheduled to report earnings on November 29, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
What were the latest earnings per share (EPS) for CERo Therapeutics Hldgs (NASDAQ:CERO)?
The Actual EPS was $-0.15, which missed the estimate of $0.00.
What were CERo Therapeutics Hldgs’s (NASDAQ:CERO) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.